COPILOT PROUDLY ANNOUNCES THE RETURN OF ANNE CHIOTTI AS EXECUTIVE PHARMACIST

“Veteran Pharmacist Anne Chiotti Rejoins COPILOT as Executive Pharmacist”

SCOTTSDALE, Ariz., Nov. 26, 2024 /PRNewswire/ — COPILOT Provider Support Services, LLC, is excited to welcome back Dr. Anne Chiotti as the Executive Pharmacist. With over 20 years of experience in the pharmacy industry and a proven history of excellence in patient-centered care, Dr. Chiotti’s return marks an important milestone in COPILOT’s mission to streamline access to specialty therapies.

Dr. Chiotti re-joins COPILOT from CenterWell (Humana), where she served as a Senior Specialty Operations Pharmacist. Her earlier tenure at COPILOT included establishing the company’s first non-dispensing pharmacy in 2020 as a Clinical Pharmacist. In her new role, she will oversee pharmacy operations, including case management for HUB programs, pharmacovigilance, and the development of adherence programs to support patients requiring specialty medications.

“We are thrilled to have Anne back on our team,” said Chuck Stevens, CEO of COPILOT. “Her expertise and passion for improving patient outcomes make her a critical leader in our organization. Her ability to navigate complex pharmacy operations and champion patient care aligns perfectly with our vision.”

Dr. Chiotti’s extensive background includes specialties in infusional oncology, sterile compounding, oral oncology, immunologic therapies, and genetics research. Beyond her roles at COPILOT and Humana, her career highlights include leading COVID vaccine clinics as the Lead Vaccinating Pharmacist for CVS and providing clinical support at Yuma Regional Medical Center, where she worked across oncology, cardiology, and other inpatient units.

She holds a Doctor of Pharmacy degree from The Ohio State University, an M.S. in Cancer Biology from Roswell Park Cancer Institute, and a B.S. in Pharmaceutical Science from SUNY Buffalo.

“I am excited to rejoin COPILOT and continue working to simplify access to specialty therapies for patients in need,” said Dr. Chiotti. “My passion for patient-centered care has only deepened, and I look forward to leading pharmacy operations to deliver impactful solutions.”

About COPILOT
COPILOT’s innovative technology delivers highly accurate and timely benefits investigation, empowering provider staff and practice management to navigate the complexities of reimbursement for complex, high-cost specialty products. Our real-time portal offers secure and easily accessible data, providing valuable insights that support both provider offices and Pharma clients in effectively managing each patient’s journey. Backed by an experienced team with deep expertise in HUB and reimbursement services, COPILOT offers unparalleled guidance in market access and ensures high satisfaction.
For more information, please visit www.cmcopilot.com

Media Contact:
Alexis Abella
AAbella@cmcopilot.com
347-287-5355

View original content to download multimedia:https://www.prnewswire.com/news-releases/copilot-proudly-announces-the-return-of-anne-chiotti-as-executive-pharmacist-302315710.html

SOURCE COPILOT Provider Support Services

Staff

Recent Posts

RiDYMO® Designs Cyclic Peptide for “Undruggable” β-Catenin Target Within Two Months

BEIJING, Jan. 8, 2025 /PRNewswire/ -- In a recent achievement, DP Technology's hit discovery platform RiDYMO® has…

43 minutes ago

ITRI Opens CES 2025 With Trend-Leading Showcase and Partnership With Reliance Biotech Corporation

LAS VEGAS, Jan. 8, 2025 /PRNewswire/ -- The Industrial Technology Research Institute (ITRI) initiated its presence…

43 minutes ago

NOTICE OF DATA BREACH

LOS ANGELES, Jan. 8, 2025 /PRNewswire/ -- Dear members of the STIIIZY community:  Stiiizy, Inc.…

43 minutes ago

Ascent Strategy Group Recognized by Modern Healthcare’s Best in Business, Affirms Health Equity Mission Amid Alarming Disparities

Agency Founder nominated Outstanding Agency Professional, Innovator of the Year First public relations agency built…

43 minutes ago

Onco-Innovations Provides Information Regarding Exclusive License for Patented Drug with Potential to Enhance Cancer Treatment Options

VANCOUVER, BC / ACCESSWIRE / January 8, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or…

4 hours ago

cbdMD Announces Additional Conversions of Its Convertible Notes

Charlotte, North Carolina--(Newsfile Corp. - January 8, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

7 hours ago